CDK ASSOCIATES, L.L.C.
CIK 1576081 · last filed 2019-11-25
CDK ASSOCIATES, L.L.C. is a corporate insider who has filed 5 SEC Form 4 insider transactions across 4 companies since 2014. The most recent filing shows the insider bought $15.0M of MTEM on Nov 25, 2019. Across all open-market trades the lifetime net is +$27.5M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $41 across reported positions. The firm reports its address in Princeton, NJ. 24 SEC filings were submitted jointly with CAXTON CORP.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
MTEM price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
731 ALEXANDER ROAD, BUILDING #2
PRINCETON, NJ 08540
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Molecular Templates, Inc. (MTEM) Delisted | Director | 136,866 | $0.00 | $14 | $15.00M | 1 | 2019-11-25 |
| Strongbridge Biopharma plc (SBBP) Delisted | 10%+ Owner | 6,531,908 | $2.00 | $13.06M | $2.83M | 1 | 2018-12-21 |
| KALA | 10%+ Owner | 220 | $0.19 | $41 | $9.68M | 1 | 2017-07-21 |
| Celator Pharmaceuticals Inc (CPXX) Delisted | 564,222 | — | — | $0 | 2 | 2016-06-22 |
Recent Filings
5 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-11-25 | Molecular Templates, Inc. (MTEM) Delisted | Buy (P) | +1,875,000 | $15.00M | EDGAR |
| 2018-12-21 | Strongbridge Biopharma plc (SBBP) Delisted | Buy (P) | +711,237 | $2.83M | EDGAR |
| 2017-07-21 | KALA | Mixed | +2,291,265 | $9.68M | EDGAR |
| 2016-06-22 | Celator Pharmaceuticals Inc (CPXX) Delisted | Gift (G) | −271,491 | $0 | EDGAR |
| 2014-11-21 | Celator Pharmaceuticals Inc (CPXX) Delisted | Buy (P) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.